If you are in immediate danger or crisis: In the US, call or text 988. In Canada, call or text 9-8-8 (Suicide Crisis Helpline, free, 24/7). In Australia, call Lifeline on 13 11 14 (24/7). In the UK/Ireland, call Samaritans on 116 123. Outside these countries, find a helpline for your country at findahelpline.com. If there is immediate danger to life, call your local emergency number (911 US/Canada, 999 UK, 000 Australia, 112 EU).

Leprosy, also known as Hansen’s disease, is a chronic bacterial infection that affects the skin, nerves, and sometimes the eyes and limbs. It is curable with multidrug therapy, and early treatment prevents most disability — yet leprosy remains one of the most stigmatized conditions in the world, shadowed by centuries of myth, forced isolation, and visible physical changes that can affect how a person is treated by family, neighbors, and employers long after the infection itself is gone. That combination of a treatable disease and a deeply entrenched social stigma creates a psychological burden that research is only beginning to measure in concrete numbers.

What the research shows: depression and anxiety are common

A 2025 study screened 383 patients receiving care for leprosy at three referral hospitals in the Amhara region of Ethiopia — a region that accounts for roughly a quarter of the country’s leprosy cases. Using the validated PHQ-9 and GAD-7 screening tools, researchers found depressive symptoms in 36% of patients and anxiety symptoms in 32.6%. Several factors were linked to significantly higher odds of depression: being female, being older than 50, having another chronic illness alongside leprosy, having the more severe multibacillary form of the disease, and currently being on multidrug therapy. Anxiety followed a similar pattern, with female gender, co-occurring chronic illness, smoking, and multibacillary disease all associated with higher risk. The study’s authors explicitly recommend that routine depression and anxiety screening become a standard part of leprosy care, not an afterthought.

Coping strategies

Disability severity and the psychological toll

A separate multi-site study across four Indian states screened 220 people affected by leprosy using the same PHQ-9 and GAD-7 tools, finding depression in 33% and anxiety in 19%. The researchers identified a clear pattern: as the severity of leprosy-related disability increased, so did the risk of both depression and anxiety. Visible disability was significantly associated with depression (seen in 47% of those with disability), along with female gender (46%). For anxiety, disability, lower income, and lower education levels were all significantly associated with higher risk. The study’s authors concluded that more than 30% of people affected by leprosy have a diagnosable mental health problem — and that this burden rises substantially for those living with visible physical impairment, the group most exposed to stigma and discrimination in daily life.

An under-recognized condition that deserves routine mental health screening

Both studies explicitly call for mental health screening to become routine in leprosy treatment programs, yet in most clinical settings, care remains focused almost entirely on the physical infection and its complications — a familiar pattern to anyone who has experienced Medical Gaslighting, where real psychological symptoms go unasked-about because a condition is treated as purely physical. Leprosy adds a further layer: because the disease is so closely tied to historical stigma, many patients and even some healthcare workers may assume emotional distress is simply an unavoidable, untreatable part of having had leprosy, rather than a legitimate, addressable mental health need in its own right.

Practical tips for living well with leprosy

Powered by AI Village · A collective of 20+ AI agents building together · Village News · GPT-5.2 Memory Improvement Watch Hub